Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2

PHASE3CompletedINTERVENTIONAL
Enrollment

1,057

Participants

Timeline

Start Date

October 6, 2021

Primary Completion Date

April 14, 2022

Study Completion Date

April 14, 2022

Conditions
Immunization Against COVID-19
Interventions
DRUG

Ergoferon

Tablet for oral use.

DRUG

Placebo

Tablet for oral use.

Trial Locations (33)

97762

City polyclinic # 74, Saint Petersburg

117593

Central Clinical Hospital of the Russian Academy of Sciences, Moscow

119285

"Llc Verum Medical", Moscow

150030

Clinical Hospital # 2/Therapeutic department, Yaroslavl

150040

Central City Hospital, Yaroslavl

150042

Clinical Hospital # 9/Polyclinic #1, Yaroslavl

190121

"LLC BioTechService", Saint Petersburg

191119

"LLC Research Center Eco-safety", Saint Petersburg

193312

City Polyclinic # 25 of the Nevsky District, Saint Petersburg

194156

"LLC Energy of Health", Saint Petersburg

196143

"LLC Research Center Eco-safety", Saint Petersburg

196158

"LLC Clinic Zvezdnaya", Saint Petersburg

196211

City Polyclinic # 51, Saint Petersburg

197198

City Polyclinic # 34, Saint Petersburg

198328

City polyclinic #106, Saint Petersburg

199406

"LLC Meili", Saint Petersburg

236016

Baltic Federal University named after Immanuel Kant, Kaliningrad

308000

Belgorod State National Research University, Department of Hospital Therapy, Belgorod

344068

City Emergency Hospital of Rostov-on-Don, Rostov-on-Don

350015

Specialized Clinical Infectious Diseases Hospital/Vaccination room, Krasnodar

350063

Kuban State Medical University, Infectious Diseases and Phthisiopulmonology, Krasnodar

355000

"LLC Scientific Medical Center for General Therapy and Pharmacology", Stavropol

410005

"LLC DNA Research Center", Saratov

410012

Saratov State Medical University named after V. I. Razumovsky, Saratov

420012

Kazan State Medical University/Department of Internal Diseases, Kazan'

420110

Republican Clinical Infectious Diseases Hospital named after Prof. A.F. Agafonov, Kazan'

426063

City Clinical Hospital # 9 of the Ministry of Health of the Udmurt Republic, Izhevsk

440067

Clinical Hospital # 4, Penza

443056

Samara City Hospital # 4, Samara

450008

Bashkir State Medical University, Internal Medicine Department, Ufa

603140

Road Clinical Hospital at the station Nizhny Novgorod of JSC Russian Railways, Nizhny Novgorod

610027

Kirov State Medical University, Hospital Therapy Department, Kirov

620137

Central City Hospital # 7, Yekaterinburg

Sponsors
All Listed Sponsors
lead

Materia Medica Holding

INDUSTRY

NCT05069649 - Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2 | Biotech Hunter | Biotech Hunter